Pharmaceutical Industry Takes Increasing Patient Focus

At Cambridge Therapeutics, Chairman John Klein and his team have produced a range of innovations in drug packaging that improve patient adherence to their prescription regimens. This focus on making dosage and usage simple and easy to understand for a patient or caregiver is in keeping with a growing trend in the pharmaceutical industry. John Klein and Cambridge Therapeutics understand that putting people first is not only the right thing to do: it makes sound business sense in today’s consumer-powered marketplace.

In noting this trend, experts point out that in the heavily regulated pharmaceutical industry, patient input into new drug approval and access to markets can make or break a product. In this environment, the issue of maintaining quality while containing costs has generated urgent concern on the part of patients. One result: Pharmaceutical firms now routinely bring patients into the discussion at multiple stages of product development and launch. 

According to a number of experts, strategic leveraging of this emerging patient-centric worldview can produce increasingly high-value, affordable treatments, as well as greater adherence, improved healthcare outcomes, and better patient satisfaction. 

Forward-thinking pharmaceutical firms that have set these as desired goals are better poised to take advantage of today’s democratized marketplace, in which patients empower themselves through greater access to information, advocacy groups, and online tools that amplify their voices.